New PET tracer aims to sharpen cancer detection
NCT ID NCT07301801
First seen Jan 11, 2026 · Last updated May 01, 2026 · Updated 14 times
Summary
This early-phase study is testing a new imaging agent called 68Ga-FL-031 for PET scans in people with suspected or confirmed small cell lung cancer, breast cancer, nasopharyngeal carcinoma, and other tumors. The goal is to see if this new tracer can better identify tumors and their spread compared to standard FDG-PET scans. Researchers will also check if the scan results match the amount of a specific protein (SSTR2) found in tumor tissue. Only 10 participants will be enrolled to gather initial data.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Wuhan Union Hospital
RECRUITINGWuhan, Hubei, 430022, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.